Iodine, Thyroid, and Hormone Optimization

A patient came to me with a bottle of 12.5 mg iodine drops she had bought after listening to a podcast. She had been taking it for four months. She felt worse — more anxious, heart racing intermittently, sleep more disrupted. Her TSH had moved from 2.1 to 6.8, her TPO antibodies had climbed from 18 to 340, and she had a small goiter on exam that had not been there at her last visit. She thought she was supporting her thyroid. What she had actually done was push a borderline autoimmune thyroid into active Hashimoto's flare with a supraphysiologic iodine dose her selenium status could not buffer.

I see a version of this several times a year. Iodine has become a wellness-internet darling, and the conversation around it has lost the nuance that actually matters clinically. Iodine is essential for thyroid function. It is also one of the most easily mishandled supplements on the market, and the patients who get hurt by it are typically the ones who needed the most careful evaluation before they started.

This article is the conversation I have with patients who walk in either taking iodine without indication or considering it without understanding the risk profile. The short version is that iodine status matters, the right dose is small and specific, and the workup before any supplementation is non-negotiable.

Why iodine matters — and why "more" is not the right framing

Iodine is the structural element in thyroid hormone. T4 is tetra-iodothyronine: four iodine atoms attached to a tyrosine backbone. T3 is tri-iodothyronine: three iodine atoms. Without iodine, the thyroid cannot synthesize hormone. Severe iodine deficiency produces goiter, hypothyroidism, and in fetal exposure, cretinism.

The U.S. solved population-level iodine deficiency in the 1920s by iodizing table salt. The recommended daily intake is 150 mcg for adults and 220 mcg for pregnant women — micrograms, not milligrams. That is the dose the thyroid is built to handle. The 12.5 mg dose in the bottle that patient brought in is 12,500 mcg — roughly 80 times the RDA. The physiology was never designed to process that.

Where things get genuinely complicated is in the tail of the population that actually is iodine-deficient. Patients who do not use iodized salt, who avoid dairy and seafood, who eat heavily processed food (which uses non-iodized salt), or who are pregnant or breastfeeding can run into real iodine insufficiency. The right intervention there is small, measured, and supervised — not a 12.5 mg drop chased with another one tomorrow.

The U-shaped curve and why most "iodine support" goes wrong

Iodine has a U-shaped relationship with thyroid disease. Both deficiency and excess increase the risk of dysfunction. The deficiency end produces goiter and hypothyroidism. The excess end produces three distinct problems:

1. Iodine-induced hypothyroidism (the Wolff-Chaikoff effect). Acute high-dose iodine triggers the thyroid to temporarily shut down hormone synthesis. In a healthy thyroid this is a transient protective mechanism that resolves in 1 to 2 days. In an autoimmune or already-stressed thyroid, the escape from Wolff-Chaikoff can fail, producing sustained hypothyroidism.
2. Iodine-induced hyperthyroidism (the Jod-Basedow effect). In a thyroid with autonomous nodular tissue, a sudden iodine load can trigger excess hormone production. Patients with previously undiagnosed nodular goiter are at risk.
3. Acceleration of autoimmune thyroid disease. This is the most common problem I see. Excess iodine in a patient with Hashimoto's autoimmunity drives TPO antibody production and can convert a well-controlled or subclinical autoimmune picture into an active flare. The patient I described at the top of this article is the textbook example.

Roughly 10 to 15 percent of the U.S. adult population has Hashimoto's autoimmunity — many of them undiagnosed because they have never had antibodies measured. That is the population most at risk from over-the-counter iodine supplementation, and that is the population most likely to be told by wellness influencers that they need it.

This is why I will not green-light iodine supplementation without measuring TPO and thyroglobulin antibodies first.

The selenium question

Iodine and selenium are physiologically linked. Selenium is the cofactor for the deiodinase enzymes that convert T4 to active T3, and for glutathione peroxidase, the antioxidant enzyme that protects thyroid tissue from the oxidative byproducts of hormone synthesis.

In selenium-deficient states, high-dose iodine produces more oxidative damage to the thyroid because the protective selenium-dependent enzymes are not available to mop up the byproducts. Studies in selenium-deficient populations show that iodine repletion alone can worsen thyroid autoimmunity, while combined iodine and selenium repletion improves it.

Practical implication: if iodine status is genuinely low and warrants intervention, selenium status needs to be addressed concurrently. I check selenium when iodine repletion is being considered, and I usually pair any iodine intervention with 100 to 200 mcg of selenium per day from a defensible source. More selenium than that is its own toxicity risk — selenium has its own narrow therapeutic window.

How I evaluate iodine and thyroid status

Iodine status is harder to measure than most patients realize. Serum iodine is unreliable because it fluctuates with intake. The accepted clinical measure is a 24-hour urinary iodine excretion test, with median population values used as the reference. Spot urinary iodine is useful at the population level but noisy at the individual level.

My typical workup when a patient asks about iodine includes comprehensive lab work covering:

• Full thyroid panel: TSH, free T3, free T4, reverse T3, TPO antibodies, thyroglobulin antibodies. This is the foundation. I cannot evaluate iodine intervention without it.
• Selenium level when iodine repletion is on the table.
• Urinary iodine in selected patients — typically those with documented dietary patterns suggesting deficiency (no iodized salt, no seafood, no dairy) or those who are pregnant or considering pregnancy.
• Thyroid ultrasound if there is a goiter on exam, an asymmetric thyroid, or a personal or family history of nodular disease.
• Sex hormones (estradiol, progesterone, total and free testosterone, DHEA-S, SHBG) because thyroid function and sex hormones interact bidirectionally and the panel never makes sense in isolation.

Most patients who arrive convinced they need iodine actually have a different problem on labs. Their TSH is suboptimal not because of iodine deficiency but because of autoimmune drift, Hashimoto's, or the downstream effect of hormonal transition. The intervention they need is not iodine. It is appropriate thyroid management and, often, hormone optimization for the broader picture.

What I look for before recommending any iodine intervention

Three things have to be true before I will support iodine supplementation:

1. Documented evidence of low iodine status. That means urinary iodine below the WHO median, dietary history consistent with deficiency, or a clinical picture (goiter without autoimmunity, hypothyroidism unresponsive to standard support) that points to it.
2. Negative or controlled thyroid autoimmunity. TPO and thyroglobulin antibodies should be negative or stable. A patient with active Hashimoto's flare is not a candidate for iodine supplementation outside of obstetric indications managed with an endocrinologist.
3. Adequate selenium status. Either documented on labs or repleted concurrently with the iodine intervention.

If those three are met, the dose is small — typically 150 to 300 mcg per day from a controlled source (a prenatal vitamin, kelp at a verified low dose, or potassium iodide drops at a measured low dose), not a milligram-range protocol.

If those three are not met, the right answer is to address the actual underlying picture. That usually means thyroid management — sometimes including levothyroxine or a T4/T3 combination based on the conversion picture — and the broader hormonal evaluation that frames it. For mid-life patients in Columbus, Warner Robins, and the Fort Benning area I see often, this is where the conversation moves from "iodine" to a real plan that addresses what is actually wrong.

How thyroid fits into hormone optimization more broadly

Thyroid hormone interacts with every other endocrine axis. Estrogen raises thyroid-binding globulin, which can lower free T4 if total production is not increased. Cortisol elevation suppresses TSH and impairs T4 to T3 conversion. Testosterone influences thyroid receptor sensitivity. Insulin resistance and thyroid drag amplify each other.

This is why I never optimize thyroid in isolation, and why I never optimize sex hormones without confirming thyroid status. A patient on hormone optimization or men's testosterone replacement whose thyroid is suboptimal will under-respond to the hormone therapy. A patient whose thyroid is corrected without addressing concurrent estrogen or testosterone deficiency will feel better but will not reach the result the broader optimization would have produced.

The same logic applies to delivery method. Biote pellet therapy for the right candidate produces stable testosterone levels that interact predictably with thyroid status. The protocol is built around the full picture, not around any single hormone.

The concrete next step

If you have been considering iodine, taking iodine, or have been told by a previous provider that your thyroid is "fine" while you continue to feel like it is not — get the full panel run before you supplement anything. Take the hormone health assessment to focus the first visit, and book at the Columbus location or Warner Robins location. Bring any thyroid labs from the past 12 months, the bottle of any iodine or thyroid supplement you are currently taking (so I can see the actual dose), and a brief symptom timeline. The first visit gathers the data; the second visit interprets it; the plan we build will fit your physiology, not the latest internet protocol.

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

Book a ConsultationCall (762) 261-3880

About Travis →More articles →Rebuild Institute →